Stage 0 breast cancer means abnormal cells have been found in the breast, but they haven’t spread beyond the layer of tissue where they started. It’s the earliest possible stage of breast cancer, and it carries an excellent prognosis. The most common form is called ductal carcinoma in situ, or DCIS, where cells lining the milk ducts have turned cancerous but remain contained inside those ducts. “In situ” literally means “in place.”
What “Non-Invasive” Actually Means
In a healthy breast, milk ducts are lined with a layer of cells. In DCIS, some of those cells have become malignant, but they haven’t broken through the wall of the duct. They haven’t reached nearby lymph nodes, the bloodstream, or any surrounding breast tissue. Think of it like mold growing on the inside of a pipe but not yet eating through the pipe wall. Because the cancer cells are still confined, stage 0 is classified as non-invasive.
You may also hear about lobular carcinoma in situ (LCIS), which involves abnormal cells in the milk-producing glands rather than the ducts. LCIS is treated differently. It’s considered both a risk factor for developing breast cancer in the future and a possible precursor to invasive cancer, but most specialists don’t classify it the same way as DCIS. When people talk about stage 0 breast cancer, they’re almost always referring to DCIS.
How Stage 0 Is Found
DCIS rarely causes a lump you can feel. It’s almost always caught on a routine screening mammogram, which is one reason regular mammograms matter. The telltale sign is a cluster of tiny calcium deposits called microcalcifications. These show up as small white specks, like grains of salt, on the mammogram image. Calcium deposits in the breast are extremely common and usually harmless, but certain patterns raise suspicion. Calcifications clustered in one area of one breast, rather than scattered evenly across both breasts, prompt a closer look.
If the pattern looks concerning, your imaging team will take magnified views of the area. If suspicion remains, the next step is a needle biopsy, where a small tissue sample is removed using image guidance and sent to a pathologist. The pathologist examines the cells under a microscope and determines whether they’re benign, precancerous, or cancerous. That’s how a DCIS diagnosis is confirmed.
Risk of Becoming Invasive
The central question with DCIS is whether it will ever become a true invasive cancer. The honest answer is that no one can predict this with certainty for an individual case. Estimates suggest that somewhere between 20% and 50% of untreated DCIS cases would eventually transform into invasive breast cancer. That’s a wide range, and it reflects genuine uncertainty in the field. Some DCIS is slow-growing and may never cause harm, while other cases are more aggressive. Factors like the grade of the abnormal cells (how different they look from normal cells) and whether the DCIS tests positive for estrogen receptors help clarify the risk.
Because doctors can’t yet reliably distinguish harmless DCIS from dangerous DCIS in every case, most patients are offered treatment. There’s an active conversation in oncology about whether some low-risk DCIS could safely be monitored rather than treated, but that approach is still being studied.
Treatment Options
Surgery is the primary treatment for DCIS. The two main options are a lumpectomy and a mastectomy. A lumpectomy removes the abnormal tissue along with a margin of healthy tissue around it, preserving the rest of the breast. A mastectomy removes the entire breast. Most patients with DCIS are candidates for lumpectomy, and for many it’s the recommended approach.
After a lumpectomy, radiation therapy is typically recommended to reduce the chance of the DCIS returning in the same breast. Radiation can be delivered to the whole breast or, for certain patients, targeted to just the area around the original tumor site. Targeted radiation (called partial breast irradiation) is an option for patients 40 and older whose DCIS measures 2 centimeters or less, is low to intermediate grade, and has clear margins after surgery. This approach requires fewer treatment visits.
For DCIS that tests positive for estrogen receptors, hormone-blocking therapy for five years is an additional option. This medication reduces the risk of cancer developing in either breast in the future.
Genomic Testing and Radiation Decisions
One of the more meaningful developments in DCIS care is genomic testing that helps determine whether radiation is necessary after lumpectomy. A test called the Oncotype DX DCIS Score analyzes the biology of the tumor tissue and generates a personalized estimate of the risk that cancer will return in the same breast over ten years. In a study of its clinical impact, the test changed oncologists’ treatment recommendations in 28% of cases. Most of those changes were from recommending radiation to recommending against it, after the test revealed a lower risk than the oncologist had estimated. When the predicted ten-year recurrence risk falls below 10%, omitting radiation is generally considered reasonable.
What Recovery and Follow-Up Look Like
Recovery from a lumpectomy is relatively quick. Most people return to normal activities within a couple of weeks, though some soreness and swelling persist longer. If radiation follows, it’s delivered over several weeks in daily sessions, each lasting only minutes. Side effects are usually limited to skin irritation and fatigue in the treated area.
After treatment, you’ll continue with regular mammograms and clinical breast exams, typically every six to twelve months for the first few years and then annually. The purpose of this surveillance is to catch any recurrence early. When DCIS does recur, about half the time it returns as DCIS again, and the other half as invasive cancer. That’s why follow-up matters even after successful treatment.
Prognosis for Stage 0
The outlook for stage 0 breast cancer is very favorable. With treatment, the vast majority of people with DCIS are cured and never develop invasive breast cancer. Long-term survival rates are essentially the same as for people who were never diagnosed with DCIS. The diagnosis can feel alarming, especially because the word “cancer” is involved, but stage 0 is fundamentally different from the invasive breast cancers that most people think of. It’s caught at the earliest possible point, before it has the ability to spread, and treatment is highly effective at keeping it that way.